GARS1 and neoplasm: Moreover, utilizing the CMIOP website, we discovered a positive correlation between GARS1 and tumor neoantigens in BRCA, DBLC, LGG, LIHC, LUAD, NSCLC, PAAD, PRAD, SARC, UCEC, and UCS (Supplementary Figure 2).